Showing results (2191-2200 of 2,234) with videos related to

Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|November 7, 2022
Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine TumorsAli Aljubran, Ahmed Badran, Mohamed Alrowaily, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 5, 2025
Diagnostic Value of 99mTc-Ubiquicidin Scintigraphy in Differentiating Bacterial from Nonbacterial PneumoniaSepideh Khoshbakht, Saba Zare, Mahdi Khatuni, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 25, 2025
Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph NodesRenata Madru, Erik Larsson, Anders Örbom, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 21, 2025
IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced CholangiocarcinomaHaijiao Yan, Qian Deng, Yu Meng, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 29, 2024
Research Progress of Hyaluronic Acid-Coated Nanocarriers in Targeted Cancer TherapyXinxin Hou, Hao Zhang
Cancer Biotherapy & Radiopharmaceuticals|October 28, 2024
Same-Day Positron Emission Tomography/Computed Tomography with 68Ga-Radiolabeled Fibroblast Activation Protein Inhibitors and 18F-Fluorodeoxyglucose Imaging for Gastrointestinal CancersXiaoshan Chen, Yunuan Liu, Xinming Zhao, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 1, 2024
microRNA-106b-5p and Rab10: Potential Markers of Acute Myeloid LeukemiaLingyue Xu, Ailing Wang, Hongzai Guan
Cancer Biotherapy & Radiopharmaceuticals|August 29, 2024
WT1 and DNMT3A Mutations in Prognostic Significance of Acute Myeloid Leukemia: A Meta-AnalysisShiyue Ma, Lingjian Tang, Hui Tang, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 21, 2024
Immune Response to Molecular Radiotherapy with 177Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy OutcomeAndreas Kluge, Richard P Baum, Norman Bitterlich, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 3, 2024
Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO StagingLi Hua, Mengzhuan Wei, Chengjun Feng, et al.
Pageof 224